These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3319914)

  • 1. High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.
    Sörgel F; Stephan U; Wiesemann HG; Gottschalk B; Stehr C; Rey M; Böwing HB; Dominick HC; Geldmacher von Mallinckrodt M
    Infection; 1987; 15(5):385-96. PubMed ID: 3319914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
    Lindsay CA; Bosso JA
    Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
    Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of antibiotics in cystic fibrosis.
    Akkerman-Nijland AM; Akkerman OW; Grasmeijer F; Hagedoorn P; Frijlink HW; Rottier BL; Koppelman GH; Touw DJ
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):53-68. PubMed ID: 33213220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.
    Touw DJ; Vinks AA; Mouton JW; Horrevorts AM
    Clin Pharmacokinet; 1998 Dec; 35(6):437-59. PubMed ID: 9884816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.
    Bulitta JB; Jiao Y; Drescher SK; Oliver A; Louie A; Moya B; Tao X; Wittau M; Tsuji BT; Zavascki AP; Shin BS; Drusano GL; Sörgel F; Landersdorfer CB
    Clin Pharmacokinet; 2019 Feb; 58(2):143-156. PubMed ID: 29936678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses.
    El Hassani M; Caissy JA; Marsot A
    Clin Pharmacokinet; 2021 Apr; 60(4):447-470. PubMed ID: 33447944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin pharmacokinetics in adult cystic fibrosis.
    Lee CKK; Boyle MP; Diener-West M; Brass-Ernst L; Noschese M; Zeitlin PL
    Chest; 2007 Mar; 131(3):796-802. PubMed ID: 17356095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of vancomycin in adult cystic fibrosis patients.
    Pleasants RA; Michalets EL; Williams DM; Samuelson WM; Rehm JR; Knowles MR
    Antimicrob Agents Chemother; 1996 Jan; 40(1):186-90. PubMed ID: 8787903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast pharmacokinetics in cystic fibrosis.
    Graff GR; Weber A; Wessler-Starman D; Smith AL
    J Pediatr; 2003 Jan; 142(1):53-6. PubMed ID: 12520255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Beta-lactam antibiotics.
    Lietman PS
    Chest; 1988 Aug; 94(2 Suppl):115S-120S. PubMed ID: 3293936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactam hypersensitivity in children with cystic fibrosis: a study in a specialized pediatric center for cystic fibrosis and drug allergy.
    Matar R; Le Bourgeois M; Scheinmann P; de Blic J; Ponvert C
    Pediatr Allergy Immunol; 2014 Feb; 25(1):88-93. PubMed ID: 24237053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic pharmacokinetics in patients with mucoviscidosis].
    Gottschalk B; Sörgel F; Wiesemann HG; Stephan U; Rey M; Böwing HB; Stehr C; Dominick HC; Kiosz D; Geldmacher-von Mallinckrodt M
    Monatsschr Kinderheilkd; 1988 Aug; 136(8):475-8. PubMed ID: 3065638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.
    Horrevorts AM; Driessen OM; Michel MF; Kerrebijn KF
    Chest; 1988 Aug; 94(2 Suppl):120S-125S. PubMed ID: 3293937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.
    Vinks AA; van Rossem RN; Mathôt RA; Heijerman HG; Mouton JW
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3049-55. PubMed ID: 17576827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic therapy in cystic fibrosis. I. Pharmacologic specifics of antibiotics].
    Sermet-Gaudelus I; Hulin A; Ferroni A; Silly C; Gaillard JL; Berche P; Lenoir G
    Arch Pediatr; 2000 May; 7(5):519-28. PubMed ID: 10855392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers.
    Bulitta JB; Duffull SB; Landersdorfer CB; Kinzig M; Holzgrabe U; Stephan U; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):130-41. PubMed ID: 19748423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis.
    Cirillo I; Vaccaro N; Redman R; Black PL; Kearns GL
    J Clin Pharmacol; 2012 Nov; 52(11):1645-53. PubMed ID: 22174436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.
    Zobell JT; Young DC; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Jun; 48(6):525-37. PubMed ID: 23359557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.